ArticleClinical and experimental immunology2013

Treatment with anti-NAP monoclonal antibody reduces disease severity in murine model of novel angiogenic protein-induced or ovalbumin-induced arthritis.

N B Nataraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.